BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/PARP4/Compounds

Compounds That Target PARP4

Protein mono-ADP-ribosyltransferase PARP4 · 7 compounds in BiohacksAI corpus

PARP4 (Protein mono-ADP-ribosyltransferase PARP4) is a biological target with 7 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into PARP4 modulation for therapeutic and biohacking applications.

View PARP4 target page →
All 7 Compounds — Ranked by Evidence
1
Olaparib
4.70
confidence
2
Rucaparib
3.58
confidence
3
Veliparib
3.47
confidence
4
Niraparib
3.30
confidence
5
Talazoparib
3.22
confidence
6
Pj34
2.64
confidence
7
Atamparib
2.30
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for PARP4 (Protein mono-ADP-ribosyltransferase PARP4). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: PARP4 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.